TBI prior to adoptive cell transfer added harm, no benefit

The addition of total body irradiation to nonmyeloablative chemotherapy prior to adoptive cell transfer does not provide any response or survival benefits but increases the risk of developing thrombotic microangiopathy (TMA), investigators reported. Sequential clinical studies in the Surgery...
Source: Skin and Allergy News - Category: Dermatology Source Type: news